HomeProductsBioactive CompoundsAnti-Infective AgentsCMVLetermovir
Chemical structure of CAS 917389-32-3

Letermovir

CAS No.917389-32-3
MDL No.N/A
MFC29H28F4N4O4
MW572.50
InChI KeyFWYSMLBETOMXAG-QHCPKHFHSA-N

Pricing & Availability

Pack SizePurityPriceAvailabilityAction
- -On RequestOn Request
Custom synthesis and bulk supply options are available upon request.

Product Information

CAS No.917389-32-3
Product NameLetermovir

Associated Conditions

pregnancy·viral disease·infection·cytomegalovirus infection·graft versus host disease
* The information provided here is compiled from public sources and is for reference only.

Related Articles

Studies related to this compound and its mechanism of action

A third component of the human cytomegalovirus terminase complex is involved in letermovir resistance.

Antiviral research • Vol. 148 • 2017
PMID: 29107686PMC: PMC5687998DOI: 10.1016/j.antiviral.2017.10.019

Mutual Interplay between the Human Cytomegalovirus Terminase Subunits pUL51, pUL56, and pUL89 Promotes Terminase Complex Formation.

Journal of virology • Vol. 91, Issue 12 • 2017
PMID: 28356534PMC: PMC5446633DOI: 10.1128/JVI.02384-16

Pharmacokinetics and safety of letermovir, a novel anti-human cytomegalovirus drug, in patients with renal impairment.

British journal of clinical pharmacology • Vol. 83, Issue 9 • 2017
PMID: 28345163PMC: PMC5555856DOI: 10.1111/bcp.13292

Letermovir and inhibitors of the terminase complex: a promising new class of investigational antiviral drugs against human cytomegalovirus.

Infection and drug resistance • Vol. 8 • 2015
PMID: 26345608PMC: PMC4531042DOI: 10.2147/IDR.S79131

Documentation

Similar Products